0 followers
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as many cancers use the TME to build barriers that shield immune syste... Read more
Laurent Audoly
Immunome
2 followers
Day One Biopharmaceuticals
1 follower
Othram
1 follower
Million Dollar Teacher Project
2 followers
SOPHiA GENETICS
4 followers
KIPP DC Public Schools
289 followers
Thermo Fisher Scientific
165 followers
Gilead Sciences
128 followers
Biogen
114 followers
Regeneron
93 followers
Pearson
59 followers
Explore companies